Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1 ☆
Titel:
Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1 ☆
Auteur:
Besse, B. Felip, E. Garcia Campelo, R. Cobo, M. Mascaux, C. Madroszyk, A. Cappuzzo, F. Hilgers, W. Romano, G. Denis, F. Viteri, S. Debieuvre, D. Galetta, D. Baldini, E. Razaq, M. Robinet, G. Maio, M. Delmonte, A. Roch, B. Masson, P. Schuette, W. Zer, A. Remon, J. Costantini, D. Vasseur, B. Dziadziuszko, R. Giaccone, G.